PPD CorEvitas Pregnancy Registries

Forty percent of all newly developed therapies will require a real-world pregnancy and/or lactation safety study. Our experienced, world-renowned perinatal epidemiologists support the design and data analysis of every observational, prospective PPD™ CorEvitas™ Pregnancy Registry cohort study to ensure rigor and success.

With access to real-time reports at individual and aggregate levels and across interim intervals, our protocol ensures you have the information you need when you need it. Whether your product is designed for use by a small or large set of individuals, we have an economical solution tailored to your needs.

Agile global infrastructure

Capable of rapid study deployment in any part of the world, our global teams can quickly assemble technical infrastructure and use native technical tools to access data rapidly and safely.

Superior study design

All study documents, including study protocol, informed consent form, questionnaire modules, and statistical analysis plans, are reviewed and approved by a world-class external scientific advisory committee.